Imaging and radiation at ASCO 2027
Jun 4–8, 2027 Chicago, IL ~44k attendees Website
17 organizations at ASCO 2027 present work in imaging and radiation: 11 diagnostics, technology and service companies and 6 drug developers. 17 of them have their own page in this guide. As of Oct 8, 2026.
Showing 1–17 of 17 organizations
| Organization | ASCO 2027 Attendance |
|---|---|
Curium Saint Louis, MO | |
Nuclear medicine company manufacturing SPECT and PET imaging agents and therapeutic radiopharmaceuticals in Europe and the US. | Booth Exhibiting at Booth 33155 |
GE HealthCare Chicago, IL | |
Medical technology company making imaging systems, PET and SPECT radiopharmaceutical diagnostics, and digital tools used in cancer diagnosis and treatment. | Booth Exhibiting at Booth 36103 |
Imaging Endpoints Scottsdale, AZ | |
Oncology imaging contract research organization managing imaging and radiology reads for solid tumor and blood cancer trials. | Booth Exhibiting at Booth 26077 |
Lantheus Bedford, MA | |
Radiopharmaceutical company whose products include Pylarify, a PSMA PET imaging agent for prostate cancer, plus therapeutic radioligand programs. | Booth Exhibiting at Booth 17157 |
Lumara Bio Princeton, NJ | |
US arm of radiopharmaceutical developer ITM, advancing targeted radioligand therapies for hard-to-treat cancers. | Booth Exhibiting at Booth 33115, 37111 |
Lunit Seoul, South Korea | |
AI software that analyzes radiology and pathology images, including tumor tissue biomarkers that may inform immunotherapy decisions. | Booth Exhibiting at Booth 14143 |
Median Technologies Valbonne, France | |
Imaging contract research organization offering central reads and AI image analysis for oncology trials; also develops AI cancer screening software. | Booth Exhibiting at Booth 37069 |
MERIT Madison, WI | |
Imaging core lab providing image collection, central reading and data management for oncology clinical trials. | Booth Exhibiting at Booth 29157 |
Novartis Basel, Switzerland | |
Global drugmaker whose cancer medicines include ribociclib for breast cancer, Pluvicto radioligand therapy for prostate cancer and blood cancer treatments. | Booth Exhibiting at Booth 15059, 15078 |
Quibim Valencia, Spain | |
Imaging biomarker company whose AI algorithms turn MRI, CT and PET scans into predictions, including regulatory-cleared medical device software. | Booth Exhibiting at Booth 31113 |
radiomics.bio Liege, Belgium | |
Imaging and statistics contract research organization using AI to assess dose impact, response and imaging biomarkers in oncology trials. | Booth Exhibiting at Booth 32113 |
RadMD Conshohocken, PA | |
Imaging contract research organization handling image analysis and radiology reads for oncology and hematology trials. | Booth Exhibiting at Booth 37119 |
RayzeBio San Diego, CA | |
Bristol Myers Squibb company developing actinium-225 radiopharmaceuticals against validated solid tumor targets, led by a program in neuroendocrine tumors. | Booth Exhibiting at Booth 14085 |
Siemens Healthineers Erlangen, Germany | |
Medical technology company whose cancer care offering spans imaging, radiation therapy planning and delivery (Varian), diagnostics and software. | Booth Exhibiting at Booth 20107 |
Telix Pharmaceuticals Melbourne, Australia | |
Radiopharmaceutical company with imaging and therapy products using targeted radiation, focused on prostate, kidney and brain cancers. | Booth Exhibiting at Booth 13131 |
Voiant Waltham, MA | |
AI-based clinical trial imaging provider managing image upload, quality control, reads and analysis to deliver imaging endpoints. | Booth Exhibiting at Booth 33130 |
Yunu Cary, NC | |
Imaging trial software that manages image capture, reader assignment, adjudication and data export for oncology studies. | Booth Exhibiting at Booth 23019 |
Instantly find 20 buyers in imaging and radiation
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse ASCO 2027 by
Organization type
Focus
- Clinical trials 58
- Biomarkers and genomics 44
- AI and data 38
- Blood cancers 36
- Lung cancer 28
- Genitourinary cancers 24
- Gastrointestinal cancers 21
- Breast cancer 18
- Immunotherapy 17
- Imaging and radiation 17
- Patient support and survivorship 14
- Antibody-drug conjugates 9
- Cell and gene therapy 8
- Melanoma and skin cancers 7
- Gynecologic cancers 6
Exhibit hall
Everyone
Not affiliated with the American Society of Clinical Oncology. Organization details are derived from ASCO’s published exhibitor list and each exhibitor’s own profile and website. Submit a correction